- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Ira Bergman, MD, PhD
- Division Director, Neurology and Child Development Unit and Professor of Pediatrics, Neurology and Immunology
- Ronald L. and Patricia M. Violi Endowed Chair in Child Development
- Interim Chief, Division of Child Development, UPMC Children's Hospital of Pittsburgh
- Director, Child Neurology Residency, UPMC Children's Hospital of Pittsburgh
Bergman has trained clinically in neurology and neuro-oncology and scientifically in cancer immunology. He is currently chief of the division of Child Neurology and Interin Chief of the Division of Child Development and program Director of the Child Neurology Residency at the University of Pittsburgh. He has extensive experience in Clinical Neurology and Medical education.
Bergman's initial research focused on clinical Neonatal Neurology and he has completed several follow-up studies of neonatal seizures, neonatal hemorrhage, hearing loss, infections and head trauma. HIs focus then switched to cancer immunotherapy and our lab developed new small animal models of leptomeningeal carcinomatosis, tested antibody therapies for neuroblastoma and breast cancer, created the first, and patented, targeted replicating recombinant virus whose cell range has been severely and specifically restricted based on modifying the viral surface glycoprotein and combined viral therapy and immunotherapy to achieve consistent cures in a mouse model of mammary cancer metastases. The lab is currently focused on testing strategies for generating and employing anti-tumor memory T-cells to prevent and treat metastases in models that highly simulate human disease, study methods to quantify the number of anti-tumor memory T-cells and study why these cells resist a wide variety of immune suppressor cells.
Professional and Scientific Society Memberships
- Child Neurology Society, 1978-Present
- American Academy of Neurology, 1978-Present
- American Academy of Pediatrics, 1981-Present
- National Stroke Association, 1989
- Children's Cancer Group Committee Membership, 1993
- American Society of Neuroimaging, 1993
- American Association of Immunology, 1998-Present
- American Association of Cancer Research, 1998-Present
- American Pediatric Society/Society for Pediatric Research, 2009-Present
Education & Training
- BA, Yale University, 1970
- MD, University of Chicago, 1974
- PhD, University of Pittsburgh, 1998
- Internship in Pediatrics, Massachusetts General Hospital, 1974-1975
- Residency in Pediatrics, Massachusetts General Hospital, 1975-1976
- Residency in Neurology (Adult Service), Massachusetts General Hospital, 1976-1977
- Residency in Neurology (Pediatric Service), Massachusetts General Hospital, 1977-1978
- Residency in Neurology (Neuropathology), Massachusetts General Hospital, 1978-1979
- Memorial Sloan Kettering Sabbatical, Neuro-Cancer Center Oncology, 1990-1991
Selected Publications
Bergman I, Whitaker-Dowling P, Gao Y, Griffin JA, Watkins WC: Vesicular Stomatitis Virus expressing a chimeric Sindbis glycoprotein containing an Fc antibody binding domain targets to Her2/neu over-expressing breast cancer cells. Virology, 2003; 316: 337-347. PMID: 14644615
Bergman I, Whitaker-Dowling P, Gao Y, Griffin JA: Preferential targeting of Vesicular Stomatitis Virus to breast cancer cells. Virology, 2004; 330: 24-33. PMID: 15527831
Miederer M, McDevitt MR, Borchardt P, Bergman I, Kramer K, Cheung NV, Scheinberg DA: Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha emitting atomic nanogenerators targeting ganglioside GD2. Clinical Cancer Research, 2004; 10: 6985-92. PMID: 15501978
Gao Y, Whitaker-Dowling P, Watkins SC, Griffin JA, Bergman I: Rapid adaptation of a recombinant Vesicular Stomatitis Virus to a targeted cell line. J. Virol, 2006; 80: 8603-8612. PMID: 16912309
Bergman I, Griffin JA, Gao Y, Whitaker-Dowling P: Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu. International Journal of Cancer, 2007; 121: 425-30. PMID: 17354238
Gao Y, Whitaker-Dowling P, Griffin JA, Barmada MA, Bergman I: Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors. Cancer Gene Therapy, 2009; 16: 44-52. PMID: 18654610
Gao Y, Whitaker-Dowling P, Griffin JA, Bergman I: Treatment with targeted Vesicular Stomatitis Virus generates therapeutic multifunctional anti-tumor memory CD4. Cancer Gene Therapy, 2012; 19: 282-91. PMID: 22240921
Gao Y, Whitaker-Dowling P, Barmada MA, Basse PH, Bergman I: Viral infection of implanted meningeal tumors induces anti-tumor memory T-cells to travel to the brain and eliminate established tumors. Neuro-Oncology 2015; 17: 536-44. PMID: 25223975
Gao Y, Whitaker-Dowling P, Bergman I: Memory anti-tumor T-cells resist inhibition by immune suppressor cells. Anticancer Research 2015: 35: 4593-97. PMID:26254347
Gao Y, Barmada MA, Bergman I: Antitumor Memory T-Cells Become Functionally Mature from 30 to 100 days in a Mouse Model of Neoplasia. Anticancer Research 2018:38:147-157. PMID: 29277767
Gao Y, Bergman I: Potent Antitumor T-Cell Memory Is Generated by Curative Viral Oncolytic Immunotherapy But Not Curative Chemotherapy. Anticancer Research 2018:38:6621-29.
Academic and Research Interests
- Immunotherapy
- Cancer
- Virus
- Quality Improvement